Biotechnology Stocks I Performance Guide: Ultragenyx Pharmaceutical Inc. (RARE)
RARE has no dividends.
Table and Chart of RARE Performance
See what a $1,000 investment in RARE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RARE Returns | |
|---|---|
| Start Date | Sep-30-2014 |
| Start Price | $56.60 |
| End Date | Sep-19-2024 |
| End Price | $58.78 |
| # Prices | 121 |
| Min Date | Oct-31-2023 |
| Min Price | $35.40 |
| Max Date | Feb-26-2021 |
| Max Price | $141.54 |
| Total Return | 3.85% |
| Annualized Return | 0.38% |
| Current Value of $1,000 Purchase | $1,039 |
| Number Returns | 7,260 |
| Average Return | -0.45% |
| Number Profitable Returns | 2,834 |
| Percent Profitable Returns | 39.04% |
| Number Unprofitable Returns | 4,426 |
| Percent Unprofitable Returns | 60.96% |
| Profitable to Unprofitable Returns Ratio | 0.64 |
| RARE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -6.460 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -515737984 |
| PE to Growth Ratio | None |
| Price to Book | 11.26 |
| PRICE DATA | |
| 52 Week High | $0.567 |
| 52 Week Low | $60.37 |
| Analyst Target Price | $0.357 |
| 50-Day Moving Average | $31.52 |
| 200-Day Moving Average | $51.5 |
| FINANCIAL DATA | |
| Revenue per Share | $-7.21 |
| Revenue | $-2 |
| Profit Margin | 595% |
| Return on Equity | -23.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RARE Compare Returns with S&P 500
RARE Trendline Chart
RARE Moving Average Chart
RARE Stock Return Map - See Patterns of Gains and Losses
RARE Stock Returns/Purchase Dates